Bocciolini Corso, Nappi Emanuele, Giunta Gianmarco, Paoletti Giovanni, Malvezzi Luca, Monti Giulia, Macchi Alberto, Amorosa Luca, Heffler Enrico
UOC of Otolaryngology, Maggiore Hospital, Bologna, Italy.
Humanitas University, Pieve Emanuele, MI, Italy.
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):913-918. doi: 10.1007/s00405-022-07629-8. Epub 2022 Aug 31.
Non allergic rhinitis (NAR) comprises different clinical definitions and phenotypes, including non inflammatory non allergic (NINAR) and cellular inflammatory forms. Nasal cytology, usually performed by scraping the inferior turbinate, is a non invasive, cheap and point-of-care tool to distinguish among the different NAR phenotypes, but still a relevant proportion of patients evaluated by nasal cytology receive a non precise definition of NAR phenotype. We hypothesize that collecting nasal cytology samples from middle meatus could increase the diagnostic accuracy.
Consecutive patients with chronic rhinitis without evidence of allergic sensitization were assessed for nasal cytology by means of scraping both the inferior turbinate and the middle meatus (lateral-inferior wall of the middle turbinate).
107 consecutive patients with NAR were enrolled in the study. According to inferior turbinate cytology, 42.1% were defined as affected by NINAR, 2.8% by bacterial rhinitis, 10.3% by non allergic rhinitis with eosinophils (NARES), 15.0% non allergic rhinitis with neutrophils (NARNE), 19.6% non allergic rhinitis with mast-cells (NARMA) and 10.3% non allergic rhinitis with eosinophils and mast-cells (NARESMA). Middle meatus cytology was in accordance with inferior turbinate cytology in only 37.6% of cases. Eosinophils and mast-cells were detectable more frequently in middle meatus samples (49.5% vs 19.6%, p < 0.01, 59.8% vs 29.9%, p < 0.01, respectively). 93.3% of NINAR patients received an inflammatory NAR phenotype at middle meatus cytology: 26.7% NARES, 24.4% NARNE, 31.1% NARMA and 11.1% NARESMA.
Middle meatus cytology is more reliable than inferior turbinate cytology in phenotyping patients with NAR. Our study strengthen that nasal cytology should be implemented in clinical practice collecting samples at the middle meatus level.
非过敏性鼻炎(NAR)包含不同的临床定义和表型,包括非炎性非过敏性(NINAR)和细胞炎性形式。鼻细胞学检查通常通过刮取下鼻甲进行,是一种区分不同NAR表型的非侵入性、廉价且即时可用的工具,但仍有相当比例通过鼻细胞学检查评估的患者未得到NAR表型的精确诊断。我们假设从中鼻道采集鼻细胞学样本可提高诊断准确性。
对连续的无变应原致敏证据的慢性鼻炎患者,通过刮取下鼻甲和中鼻道(中鼻甲外侧下壁)进行鼻细胞学评估。
107例连续的NAR患者纳入本研究。根据下鼻甲细胞学检查,42.1%被定义为受NINAR影响,2.8%为细菌性鼻炎,10.3%为嗜酸性粒细胞性非过敏性鼻炎(NARES),15.0%为中性粒细胞性非过敏性鼻炎(NARNE),19.6%为肥大细胞性非过敏性鼻炎(NARMA),10.3%为嗜酸性粒细胞和肥大细胞性非过敏性鼻炎(NARESMA)。中鼻道细胞学检查仅在37.6%的病例中与下鼻甲细胞学检查结果一致。嗜酸性粒细胞和肥大细胞在中鼻道样本中更频繁地被检测到(分别为49.5%对19.6%,p < 0.01;59.8%对29.9%,p < 0.01)。93.3%的NINAR患者在中鼻道细胞学检查中获得炎性NAR表型:26.7%为NARES,24.4%为NARNE,31.1%为NARMA,11.1%为NARESMA。
在对NAR患者进行表型分析时,中鼻道细胞学检查比下鼻甲细胞学检查更可靠。我们的研究强化了在临床实践中应在中鼻道水平采集样本进行鼻细胞学检查的观点。